XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities:    
Net income (loss) $ 26,683 $ (55,848)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 134,894 100,087
Stock-based compensation expense 45,300 53,573
Deferred taxes (18,019) (78,004)
Gain from divested operations (25,460) 0
Amortization and write-off of deferred financing fees 10,601 9,475
Changes in assets and liabilities, net of acquisitions and divestitures:    
Fees receivable, net 81,222 (44,939)
Deferred commissions 21,818 477
Prepaid expenses and other current assets (82,908) (22,453)
Other assets 23,862 (17,328)
Deferred revenues 87,316 167,412
Accounts payable, accrued, and other liabilities (128,562) (29,734)
Cash provided by operating activities 176,747 82,718
Investing activities:    
Additions to property, equipment and leasehold improvements (40,126) (41,627)
Acquisitions - cash paid (net of cash acquired) 0 (2,604,178)
Divestitures - cash received (net of cash transferred) 405,542 0
Other 1,000 0
Cash provided by (used in) investing activities 366,416 (2,645,805)
Financing activities:    
Proceeds from employee stock purchase plan 7,627 5,662
Proceeds from borrowings 0 2,885,000
Payments for deferred financing fees 0 (51,170)
Payments on borrowings (858,609) (119,812)
Purchases of treasury stock (96,271) (33,786)
Cash (used in) provided by financing activities (947,253) 2,685,894
Net (decrease) increase in cash and cash equivalents and restricted cash (404,090) 122,807
Effects of exchange rates on cash and cash equivalents and restricted cash (3,012) 10,406
Cash and cash equivalents and restricted cash, beginning of period 159,956 632,567
Cash and cash equivalents and restricted cash, end of period $ 567,058 $ 499,354